Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 50705 / DOSAGE - TABLET;ORAL - 50MG;300MG;120MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| isoniazid(UNII: V83O1VOZ8L) (isoniazid - UNII:V83O1VOZ8L) | isoniazid | 50mg |
| pyrazinamide(UNII: 2KNI5N06TI) (pyrazinamide - UNII:2KNI5N06TI) | pyrazinamide | 300mg |
| rifampin(UNII: VJT6J7R4TR) (rifampin - UNII:VJT6J7R4TR) | rifampin | 120mg |
Inactive Ingredients
| Ingredient Name | sanofi-aventis U.S. LLC |
|---|---|
| acacia(5C5403N26O) | |
| aluminum hydroxide(5QB0T2IUN0) | |
| calcium stearate(776XM7047L) | |
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM(K679OBS311) | |
| carnauba wax(R12CBM0EIZ) | |
| ferric oxide red(1K09F3G675) | |
| ferrosoferric oxide(XM0M87F357) | |
| kaolin(24H4NWX5CO) | |
| lecithin, soybean(1DI56QDM62) | |
| magnesium carbonate(0E53J927NA) | |
| PARAFFIN(I9O0E3H2ZE) | |
| POVIDONE, UNSPECIFIED(FZ989GH94E) | |
| propylene glycol(6DC9Q167V3) | |
| rosin(88S87KL877) | |
| shellac(46N107B71O) | |
| silicon dioxide(ETJ7Z6XBU4) | |
| sodium lauryl sulfate(368GB5141J) | |
| sucrose(C151H8M554) | |
| talc(7SEV7J4R1U) | |
| titanium dioxide(15FIX9V2JP) | |
| white wax(7G1J5DA97F) |
